-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment [CME/CPE

Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care Organizations

ByJeffrey D. Dunn, PharmD, MBA,Nancy A. Nickman, PhD

May 8th 2012

Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment

By

May 8th 2012

Participating Faculty: Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment

By

May 7th 2012

Clinical and Humanistic Aspects of Growth Hormone Deficiency and Growth-Related Disorders

ByAlan D. Rogol, MD, PhD

May 7th 2012

Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan Setting

ByNancy A. Nickman, PhD,Jeffrey D. Dunn, PharmD, MBA

May 7th 2012

Trending on AJMC

Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH

IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness

Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36

FDA Approves Talazoparib Plus Enzalutamide for HRR-Mutated mHSPC

Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care